CYTOSORBENTS CORPORATION (CTSO) Total liabilities 2016–2025
CYTOSORBENTS CORPORATION (CTSO) total liabilities at each fiscal year-end, per SEC filings.
$38.3MFY2025 · since FY2016: $8.4M → $38.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $38.3M | +5.6% |
| FY2024 | $36.3M | +23.0% |
| FY2023 | $29.5M | +5.8% |
| FY2022 | $27.9M | +3.4% |
| FY2021 | $26.9M | +151.0% |
| FY2020 | $10.7M | -55.2% |
| FY2019 | $24.0M | +38.8% |
| FY2018 | $17.3M | +24.7% |
| FY2017 | $13.8M | +65.6% |
| FY2016 | $8.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice